KATHERINE CUNHA: Open Payments
NPI 1699242776 · HUNTINGTON BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,497 in 12 payments from 7 companies in 2025. Trend: 2023 $762 · 2024 $1,827 · 2025 $1,497
Food & beverage: $1,497
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $482 |
| Janssen Biotech, Inc. | 3 | $429 |
| Agios Pharmaceuticals, Inc. | 1 | $125 |
| Astellas Pharma US Inc | 1 | $124 |
| GlaxoSmithKline, LLC. | 1 | $120 |
| Caris MPI, Inc. | 1 | $114 |
| Novartis Pharmaceuticals Corporation | 1 | $103 |
Products named: RYBREVANT, OPDIVO, BREYANZI, PYRUKYND, Padcev, ZEJULA, MI CANCER SEEK, SCEMBLIX.
Industry payments across CA — which companies pay providers there.
